Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Staying Safe Intervention: Preventing HCV Among Young Opioid Injectors

NCT03418636 is registered in ClinicalTrials.gov with National Development and Research Institutes, Inc. as lead sponsor.

NCT NCT03418636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Staying Safe Intervention: Preventing HCV Among Young Opioid Injectors
Lead sponsor
National Development and Research Institutes, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2018
Completion date
May 31, 2021
Enrollment
456 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, opioid use